PMID- 33743582 OWN - NLM STAT- MEDLINE DCOM- 20210426 LR - 20210426 IS - 1471-2318 (Electronic) IS - 1471-2318 (Linking) VI - 21 IP - 1 DP - 2021 Mar 20 TI - Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study. PG - 197 LID - 10.1186/s12877-021-02141-w [doi] LID - 197 AB - BACKGROUND: A precondition for developing strategies to reduce polypharmacy and its well-known harmful consequences is to study its epidemiology and associated factors. The objective of this study was to analyse the prevalence of polypharmacy (defined as >/=8 prescribed drugs), of potentially inappropriate medications (PIMs) and major drug-drug interactions (DDIs) among community-dwelling general practice patients aged >/=75 years and to identify characteristics being associated with polypharmacy. METHODS: This cross-sectional study is derived from baseline data (patients' demographic/biometric characteristics, diagnoses, medication-related data, cognitive/affective status, quality of life) of a northern-Italian cluster-RCT. PIMs and DDIs were assessed using the 2012 Beers criteria and the Lexi-Interact(R) database. Data were analysed using descriptive methods, Wilcoxon rank-sum tests, Fisher's exact tests and Spearman correlations. RESULTS: Of the eligible patients aged 75+, 13.4% were on therapy with >/=8 drugs. Forty-three general practitioners and 579 patients participated in the study. Forty five point nine percent of patients were treated with >/=1 Beers-listed drugs. The most frequent PIMs were benzodiazepines/hypnotics (19.7% of patients) and NSAIDs (6.6%). Sixty seven point five percent of patients were exposed to >/=1 major DDI, 35.2% to >/=2 major DDIs. Antithrombotic/anticoagulant medications (30.4%) and antidepressants/antipsychotics (23.1%) were the most frequently interacting drugs. Polypharmacy was significantly associated with a higher number of major DDIs (Spearman's rho 0.33, p < 0.001) and chronic conditions (Spearman's rho 0.20, p < 0.001), higher 5-GDS scores (thus, lower affective status) (Spearman's rho 0.12, p = 0.003) and lower EQ-5D-5L scores (thus, lower quality of life) (Spearman's rho - 0.14, p = 0.001). Patients' age/sex, 6-CIT scores (cognitive status), BMI or PIM use were not correlated with the number of drugs. CONCLUSIONS: The prevalence of polypharmacy, PIMs and major DDIs was considerable. Results indicate that physicians should particularly observe their patients with multiple conditions, reduced health and affective status, independently from other patients' characteristics. Careful attention about indication, benefit and potential risk should be paid especially to patients on therapy with specific drug classes identified as potentially inappropriate or prone to major DDIs in older persons (e.g., benzodiazepines, NSAIDs, protonic pump inhibitors, antithrombotics/anticoagulants, antidepressants/antipsychotics). TRIAL REGISTRATION: The cluster-RCT on which this cross-sectional analysis is based was registered with Current Controlled Trials Ltd. (ID ISRCTN: 38449870 ) on 2013-09-11. FAU - Piccoliori, Giuliano AU - Piccoliori G AD - Institute of General Practice and Public Health, College of Health Care Professions, Lorenz Bohler- Strasse 13, 39100, Bolzano, Italy. AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Mahlknecht, Angelika AU - Mahlknecht A AUID- ORCID: 0000-0002-5280-5447 AD - Institute of General Practice and Public Health, College of Health Care Professions, Lorenz Bohler- Strasse 13, 39100, Bolzano, Italy. angelika.mahlknecht@am-mg.claudiana.bz.it. AD - Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University, Strubergasse 21, 5020, Salzburg, Austria. angelika.mahlknecht@am-mg.claudiana.bz.it. FAU - Sandri, Marco AU - Sandri M AD - Big & Open Data Innovation Laboratory (BODaI-Lab), University of Brescia, Via S. Faustino 74/B, 25122, Brescia, Italy. FAU - Valentini, Martina AU - Valentini M AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Vogele, Anna AU - Vogele A AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Schmid, Sara AU - Schmid S AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Deflorian, Felix AU - Deflorian F AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Engl, Adolf AU - Engl A AD - Institute of General Practice and Public Health, College of Health Care Professions, Lorenz Bohler- Strasse 13, 39100, Bolzano, Italy. AD - South Tyrolean Academy of General Practice, Wangergasse 18, 39100, Bolzano, Italy. FAU - Sonnichsen, Andreas AU - Sonnichsen A AD - Department of General Practice and Family Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15/I, 1090, Vienna, Austria. FAU - Wiedermann, Christian AU - Wiedermann C AD - Institute of General Practice and Public Health, College of Health Care Professions, Lorenz Bohler- Strasse 13, 39100, Bolzano, Italy. AD - UMIT - Private University for Health Sciences, Medical Informatics and Technology - Tyrol, Eduard-Wallnofer-Zentrum 1, 6060, Hall in Tirol, Austria. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210320 PL - England TA - BMC Geriatr JT - BMC geriatrics JID - 100968548 SB - IM MH - Aged MH - Aged, 80 and over MH - Cross-Sectional Studies MH - Humans MH - *Inappropriate Prescribing MH - Italy/epidemiology MH - *Polypharmacy MH - Potentially Inappropriate Medication List MH - Primary Health Care MH - Quality of Life PMC - PMC7981991 OTO - NOTNLM OT - Drug interactions OT - General practice OT - Inappropriate prescribing OT - Older adults OT - Polypharmacy COIS- All authors declare that they have no competing interests. EDAT- 2021/03/22 06:00 MHDA- 2021/04/27 06:00 PMCR- 2021/03/20 CRDT- 2021/03/21 20:25 PHST- 2021/01/15 00:00 [received] PHST- 2021/03/02 00:00 [accepted] PHST- 2021/03/21 20:25 [entrez] PHST- 2021/03/22 06:00 [pubmed] PHST- 2021/04/27 06:00 [medline] PHST- 2021/03/20 00:00 [pmc-release] AID - 10.1186/s12877-021-02141-w [pii] AID - 2141 [pii] AID - 10.1186/s12877-021-02141-w [doi] PST - epublish SO - BMC Geriatr. 2021 Mar 20;21(1):197. doi: 10.1186/s12877-021-02141-w.